Form 4: Hims & Hers CFO Executes Planned Stock Sale
Statement of Changes in Beneficial Ownership
Chief Financial Officer Oluyemi Okupe sold shares of Hims & Hers Health, Inc. under a pre-established Rule 10b5-1 trading plan.
Summary
- CFO Oluyemi Okupe sold a total of 54,927 shares of Class A Common Stock across two transactions on April 16 and April 17, 2026.
- The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025.
- The CFO exercised options for 6,184 shares at a strike price of $5.01 on April 17, 2026.
- Following these transactions, the reporting person maintains direct ownership of 270,046 shares and indirect ownership of 7,853 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transactions were pre-planned and represent routine portfolio management by an executive.
Positives
- Transactions were conducted under a pre-arranged Rule 10b5-1 plan, indicating the sales were scheduled in advance rather than based on non-public information.
- The reporting person retains a significant equity stake of 277,899 total shares.
Negatives
- The filing reflects a net reduction in the CFO's direct share ownership.
Risks
- Future sales by insiders may occur as part of the ongoing Rule 10b5-1 trading plan.
Future Outlook
No specific forward-looking guidance provided; the filing relates strictly to historical insider transaction activity.
Industry Context
StockSavvy.ai notes that insider selling via Rule 10b5-1 plans is a standard corporate practice for liquidity and diversification, and is generally viewed as neutral by the market when pre-planned.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for executives to manage equity holdings while mitigating regulatory scrutiny regarding insider trading.
Stakeholder Impact
- Minimal impact expected as the sales were executed through a pre-planned trading program.
Next Steps
- Continued monitoring of future Form 4 filings for additional transactions under the established 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 2022-01-24 | Vesting Commencement Date for stock options. |
| 2025-05-21 | Adoption date of the Rule 10b5-1 trading plan. |
| 2026-04-16 | Date of first reported sale transaction. |
| 2026-04-17 | Date of option exercise and second sale transaction. |
| 2026-04-20 | Filing date of the Form 4. |
Keywords
Hims & Hers, HIMS, Insider Trading, Form 4, CFO, Stock Option Exercise, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.